Last updated on October 2017

PMS for Idarucizumab in Japan


Brief description of study

To evaluate safety and effectiveness of Prizbind® for Intravenous Solution 2.5 g under Japanese clinical condition

Clinical Study Identifier: NCT02946931

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Boehringer Ingelheim Call Center

One Or Multiple Investigational Sites, Japan
  Connect »